| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |